We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Intracytoplasmic Sperm Injection and Potential Transmission of Genetic Disease

Benjamin M. Tripp, MD; Thomas F. Kolon, MD; Collin Bishop, PhD; Larry I. Lipshultz, MD; Dolores J. Lamb, PhD
JAMA. 1997;277(12):963-964. doi:10.1001/jama.1997.03540360031020.
Text Size: A A A
Published online


To the Editor.  —Dr Palermo and colleagues1 recently reported that when intracytoplasmic sperm injection (ICSI) was used to produce pregnancy, the pregnancies, frequency of chromosomal abnormalities, and incidence of congenital abnormalities in the babies conceived in such a manner were comparable to those conceived with standard in vitro fertilization (IVF).Although this study is reassuring, its conclusions may lead to the injudicious, and sometimes inappropriate, use of ICSI and similar technology, ie, round spermatid nuclear injection. With the advent of ICSI combined with testicular sperm extraction as a therapeutic option, men with clinical azoospermia, who were once thought to be sterile and untreatable, now have the ability to procreate.A major concern with ICSI is the potential transmission of genetic disease to offspring.2 A host of known genetic diseases and syndromes can cause male infertility, and more are yet to be delineated. With the use of ICSI, these


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.